Home Authors Articles by David Orchard-Webb, PhD

David Orchard-Webb, PhD

477 ARTICLES 0 COMMENTS
David is a consultant/medical writer for a number of ongoing healthcare initiatives including for Athla LLC/ HealthLabs, a discovery automation company for Big Data leveraging Big Compute. He has a number of years experience in academic R&D and healthcare related projects including the fields of oncology and immunotherapy.

Cesca Therapeutics Inc. Has Released The X-Mini™ Cell Selection Kit For The CAR-T Research...

Two CAR-T cell therapies have been approved by the USA Food and Drug Administration (FDA) within the past year for blood cancers. Cellular therapies have been approved in the past such as Provenge for prostate cancer, the IP of...

Sekisui XenoTech Research Biobank Adds Fatty Liver Disease Assets

Sekisui XenoTech, LLC is a global Contract Research Organization (CRO). Established for almost 25 years, the company offers an ever-evolving selection of cell and tissue-based products, screening, radiolabeling, API manufacturing, in vitro ADME Tox and pharmacology, in vivo ADME...

The Frozen Ark Biobank

It has been estimated that dozens of species of plants and animals are currently experiencing extinction every day . Ecosystems are essential for the biological stability of the planet and are also great economic resources in the form of...

ISBER And The Biobank Branch, China Medicinal Biotech Association (BBCMBA) Sign Affiliate Agreement

The International Society for Biological and Environmental Repositories (ISBER) seeks to address the harmonization of scientific, technical, legal, and ethical issues relevant to repositories of biological and environmental specimens. The mission of ISBER as a global organization is to...

Owlstone Medical Boosts Breath Biopsy Research With Kits And A Digital Biobank

Dogs have been used in criminal justice and forensic science settings for many years to detect the scent of missing persons or illicit drugs for example . They can detect volatile organic chemicals with their well developed olfactory system....

23andMe Backed Study Reveals Genetic Risk Factors For Hyperemesis Gravidarum

Nausea and vomiting vary considerably in duration and severity in pregnancy but are common complaints . Hyperemesis gravidarum (HG) is a condition that occurs in 0.3–2% of pregnancies and is associated with maternal and fetal morbidity, which represents the...

Regeneron Confirms New Chronic Liver Disease Drug Target Using Biobank Data

For the first time Regeneron has reported a variant in the HSD17B13 gene that is associated with reduced risk of, in other words protection from, various chronic liver diseases for which there are currently no approved therapeutics . The...

AGC Biologics Expands Capacity At Its Berkeley Manufacturing And Cell Banking Facility

AGC Biologics is a global Contract Development and Manufacturing Organization (CDMO) of therapeutic proteins, with a strong commitment to deliver the highest standard of service. Focused on early-phase, the AGC Biologics Berkeley facility operates within the global AGC Biologics...

Research Out-Smarts Endometriosis (ROSE) Biobank Used To Develop An Experimental Diagnostic

Researchers at the Feinstein Institute, Manhasset, NY established the Research Out-Smarts Endometriosis (ROSE) program to study the genetic and cellular basis of endometriosis. Research volunteers, both healthy and those with endometriosis, provided peripheral and menstrual blood samples which are...

Abzena Plc Secures Access Agreement With A Major Cell Line Depository

Abzena plc provides proprietary technologies and complementary services to enable the development and manufacture of biopharmaceutical products. Biopharmaceuticals are protein based drugs and include antibodies, antibody-drug conjugates, therapeutic proteins and peptides. ABZENA Inside products are biopharmaceutical products that incorporate...

🔥 Most Popular



Featured Vendors
X